Feinberg
Northwestern Medicine | Northwestern University | Faculty Profiles

News Center

  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Menu
  • Categories
    • Campus News
    • Disease Discoveries
    • Clinical Breakthroughs
    • Education News
    • Scientific Advances
  • Press Releases
  • Media Coverage
  • Podcasts
  • Editor’s Picks
    • COVID-19
    • Cardiology
    • Cancer
    • Neurology and Neuroscience
    • Aging and Longevity
    • Artificial Intelligence in Medicine
  • News Archives
  • About Us
    • Media Contact
    • Share Your News
    • News Feeds
    • Social Media
    • Contact Us
Home » Protein Protects Organs From Immune Damage
Disease Discoveries

Protein Protects Organs From Immune Damage

By Nora DunneMay 7, 2015
Share
Facebook Twitter Email
defective mitophagy_400
Defective mitophagy results in accumulation of damaged mitochondria in Jnk2 deficient cells.

Northwestern Medicine scientists have identified a previously unknown key regulator of inflammasomes, a first-line immune response. The stress-activated regulator, a protein kinase known as Jnk2, promotes a physiological process called mitophagy that helps maintain cellular homeostasis.

Homeostasis is a healthy equilibrium in the body achieved through many self-regulated processes, including mitophagy, which removes damaged or excessive mitochondria from cells. When these energy-producing organelles aren’t disposed of properly, groups of proteins called inflammasomes are hyper-activated, which can lead to fatal tissue and organ damage.

The new study, published in Nature Immunology, shows that Jnk2 stimulates mitophagy, which prevents hyperactivation of the NLRP3 inflammasome multiprotein complex and maintains immune homeostasis.

“Since discovered in 2002, inflammasomes have been extensively studied. However, the regulatory mechanism that fine-tunes the activity of inflammasome has been incompletely understood,” said senior author Jing Liu, PhD, assistant professor in Medicine-Pulmonary. “Our finding provides an important breakthrough in the field of immunity.”

The finding suggests that promoting mitophagy by way of Jnk2 may protect organs from damage induced by sepsis, a complication of infection that occurs when immune response chemicals fighting harmful bacteria and toxins spread through the bloodstream and cause inflammation throughout the body.

Jing Liu, PhD, assistant professor in Medicine-Pulmonary, was senior author of a study that identified Jnk2 as a previously unknown key regulator of inflammasomes, a first-line immune response.
Jing Liu, PhD, assistant professor in Medicine-Pulmonary, was senior author of a study that identified Jnk2 as a previously unknown key regulator of inflammasomes, a first-line immune response.

“Our work also implies that targeting Jnk2-regulated mitophagy for tissue tolerance to damage may have broad applications to many pathological conditions that are associated with mitochondrial dysfunction, such as sepsis,” Liu said.

In the study, loss of Jnk2 in mouse models resulted in tissue damage under hypoxic stress, inflammasome hyperactivation and increased mortality from sepsis. They also discovered that Jnk2 targets a small mitochondrial form of a tumor suppressor called ARF, which was previously reported to induce mitophagy when over-expressed.

“Jnk2 functions as a guardian for organ integrity and thereby determines life or death under environmental stress,” the study’s authors write in the paper.

Future research will continue to examine the applications of this important protein.

“One potential translational aspect of our work is to determine whether JNK2 serves as a marker of severe sepsis and prognosis in the intensive care unit,” Liu said.

This study was supported by National Institutes of Health National Heart, Lung, and Blood Institute grant HL114763 and American Asthma Foundation grant 13-0114.

Cell and Developmental Biology Immunology Research
Share. Facebook Twitter Email

Related Posts

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

Comments are closed.

Latest News

Sex-Specific Mechanisms for Major Depressive Disorder Identified in Response to Dysregulated Stress Hormones

Mar 23, 2023

Pre-Surgery Immunotherapy May Increase Survival in Advanced Melanoma

Mar 23, 2023

Hormone Therapy Plus Current Treatments Improves Survival in Prostate Cancer

Mar 22, 2023

How ChatGPT Has, and Will Continue to, Transform Scientific Research

Mar 21, 2023

New Directions for HIV Treatment

Mar 21, 2023
  • News Center Home
  • Categories
  • Press Release
  • Media Coverage
  • Editor’s Picks
  • News Archives
  • About Us
Flickr Photos
20230317_NM651
20230317_NM610
20230317_NM569
20230317_NM537
20230317_NM331
20230317_NM323
20230317_NM316
20230317_NM336
20230317_NM626
20230317_NM662
20230317_NM655
20230317_NM642

Northwestern University logo

Northwestern University Feinberg School of Medicine

RSS Facebook Twitter LinkedIn Flickr YouTube Instagram
Copyright © 2023 Northwestern University
  • Contact Northwestern University
  • Disclaimer
  • Campus Emergency Information
  • Policy Statements

Type above and press Enter to search. Press Esc to cancel.